Clinical Trial Update: Internal Radiation Therapy for Hepatocellular Carcinomas With Therasphere: Optimized Dosimetry Versus Standard Dosimetry [Phase 2]

View source ↗

Summary

Phase 2 trial comparing optimized dosimetry to standard dosimetry in TheraSphere internal radiation therapy for hepatocellular carcinoma; the study has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• TheraSphere (yttrium-90 glass microspheres)

Snippet

Sponsor: Center Eugene Marquis | Conditions: Adenoma, Liver Cell | Phase 2 | Status: COMPLETED